Ebru Bilget Guven (Ebru Bilget Güven)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Endoplasmic Reticulum Stress

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

RSC medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Ebru Bilget Guven, Irem Durmaz Sahin, Duygu Altiparmak, Burak Servili, Şebnem Eşsiz, Rengul Cetin-Atalay, Meral Tuncbilek
Newly synthesized 6-substituted piperazine/phenyl-9-cyclopentyl containing purine nucleobase analogs act as potent anticancer agents and induce apoptosis via inhibiting Src in hepatocellular carcinoma cells. RSC medicinal chemistry 14 (12) (2023)
Ebru Bilget Guven, Irem Durmaz Sahin, Duygu Altiparmak, Burak Servili, Şebnem Eşsiz, Rengul Cetin-Atalay, Meral Tuncbilek
Newly synthesized 6-substituted piperazine/phenyl-9-cyclopentyl containing purine nucleobase analogs act as potent anticancer agents and induce apoptosis via inhibiting Src in hepatocellular carcinoma cells. RSC medicinal chemistry 14 (12) (2023)
Emre Ozan Polat, M Mustafa Cetin, Ahmet Fatih Tabak, Ebru Bilget Guven, Bengü Özuğur Uysal, Taner Arsan, Anas Kabbani, Houmeme Hamed, Sümeyye Berfin Gül
Transducer Technologies for Biosensors and Their Wearable Applications. Biosensors 12 (6) (2022)